Sort by
Refine Your Search
-
Employer
-
Field
-
2026. The research will be carried out within the newly established Centre of Excellence (CoE) in Neutron-Star Physics (https://neutronstars.fi/ ), funded by the Research Council of Finland. The CoE
-
, blending basic science, translational studies, and clinical innovation with state-of-the-art facilities for genomics, proteomics, and AI-driven discoveries. For more information, please visit https
-
6 Jan 2026 Job Information Organisation/Company University of Jyväskylä Research Field Physics » Other Researcher Profile Recognised Researcher (R2) Country Finland Application Deadline 4 Feb 2026
-
Mathematics » Statistics Mathematics » Other Researcher Profile First Stage Researcher (R1) Country Finland Application Deadline 19 Jan 2026 - 14:00 (UTC) Type of Contract Temporary Job Status Full-time Is the
-
) Application Deadline 1 Feb 2026 - 21:59 (UTC) Country Finland Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the
-
Mathematics » Statistics Mathematics » Other Researcher Profile Recognised Researcher (R2) Country Finland Application Deadline 16 Feb 2026 - 14:00 (UTC) Type of Contract Temporary Job Status Full-time Is the
-
provides support for internationally recruited employees with their transition to work and life in Finland. More information here: https://www.helsinki.fi/en/about-us/careers/welcome-finland-information
-
opportunities for professional development (https://www.helsinki.fi/en/about-us/careers ). Application should include the following documents as a single pdf file: a cover letter, a CV, a publication list the
-
occupational health care and health insurance, unemployment and pension fund, a generous holiday package, sports facilities, and opportunities for professional development (https://www.helsinki.fi/en/about-us
-
are located at the medical campuses in the University of Helsinki. The immediate research environment provides state-of-the-art facilities, cutting-edge expertise in vascular-, tumor-, immunological